Traws Pharma (TRAW) analyst forecast and price target
Analyst forecast
Consensus of 2 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Neutral | $1.00 | Aug 18, 2026 |
| HC Wainwright & Co. | Downgraded | Buy → Neutral | $1.00 | Jun 18, 2026 |
| Ladenburg Thalmann | Downgraded | Buy → Neutral | — | Jun 15, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | May 20, 2026 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $8.00 | Dec 3, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 | Oct 12, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 | Aug 11, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 | Jun 14, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 | Jun 6, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 | May 25, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 | May 16, 2023 |
Frequently asked questions
Is TRAW a buy, sell, or hold?
Analysts covering Traws Pharma currently average a Hold rating: 0 buy, 2 hold and 0 sell, from 2 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on TRAW?
On Aug 18, 2026, HC Wainwright & Co. maintained Traws Pharma at Neutral with a price target of $1.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.